Cancer after transplantation: epidemiology and novel therapies
Chris Blosser
Clinical Associate Professor of Medicine
University of Washington
Seattle, USA
Chris Blosser, MD, is a Clinical Associate Professor of Medicine at the University of Washington where he cares for adults with kidney disease, and is Director of the upcoming multidisciplinary Comprehensive Cancer & Organ Transplant Consult Clinic (CCOTCC), a partnership with SCCA and UW Transplant, to provide expert consultation for pre-and post-organ transplant patients with challenging cancer and organ transplant conditions. He also directs the Kidney Transplant Transition of Care Program from Seattle Children’s Hospital to UW Medical Center. He is focused on translational and clinical research regarding immunologic mechanisms and patient experience with cancer in pre-and post-organ transplant patients along with therapeutic interventions for various forms of allograft rejection, recurrent disease, and cancer in ESKD and organ transplant recipients.
New onset diabetes after transplantation: epidemiology and management
Wai Lim
Medical Director of Kidney Transplantation
Sir Charles Gairdner Hospital
Clinical Professor of Medicine
University of Western Australia
Perth, Australia
Wai Lim is the Medical Director of Kidney Transplantation at Sir Charles Gairdner Hospital and a Clinical Professor of Medicine at the University of Western Australia. He is the iCo-Chair of the Transplantation Society of Australia and New Zealand Scientific Program Education Committee and Chair of the Australian Kidney Trials Network Transplant working group. He holds a Ph.D. in transplant immunology focussing on dendritic cells and chronic kidney disease and his current research interests focus on the role of HLA and epitope matching in kidney allocation for transplantation, novel immunological risk profile and identifying novel risk factors and intervention to reduce the risk of cardiovascular complications in kidney transplant patients. He is the Associate Editor for Transplant International, Nephrology and Frontiers Immunology, and Alloimmunity journals and is on the editorial board for Kidney International journal.
